Cargando…
ALS plasma reduces the viability of NSC34 cells via altering mRNA expression of VEGF: A short report
INTRODUCTION: Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder that progressively leads to motor neuron degeneration at the neuromuscular junctions, resulting in paralysis in the patients. The clinical diagnosis of ALS is time taking and further delays the therapeutics...
Autores principales: | Khosla, Radhika, Bhagat, Hemant, Lal, Parth, Anand, Akshay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372388/ https://www.ncbi.nlm.nih.gov/pubmed/37519724 http://dx.doi.org/10.1016/j.heliyon.2023.e18287 |
Ejemplares similares
-
Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers
por: Khosla, Radhika, et al.
Publicado: (2021) -
Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival
por: Matta, Rita, et al.
Publicado: (2021) -
Primary Neurons and Differentiated NSC-34 Cells Are More Susceptible to Arginine-Rich ALS Dipeptide Repeat Protein-Associated Toxicity than Non-Differentiated NSC-34 and CHO Cells
por: Gill, Anna L., et al.
Publicado: (2019) -
Association of Plasma Biomarkers for Angiogenesis and Proteinopathy in Indian Amyotrophic Lateral Sclerosis Patients
por: Modgil, Shweta, et al.
Publicado: (2020) -
NSC‐34 motor neuron‐like cells are sensitized to ferroptosis upon differentiation
por: Martinez, Alejandra M., et al.
Publicado: (2019)